Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Finding the Potential Inhibitory Activity of Vilanterol versus Budesonide towards SARS-CoV-2 Mpro: A Molecular Dynamics Simulation Approach

Author(s): Afzal Hussain* and Ashfaq Hussain

Volume 4, Issue 2, 2023

Published on: 19 June, 2023

Article ID: e080523216656 Pages: 3

DOI: 10.2174/2666796704666230508140526

Price: $65

Abstract

The fast and widespread spread of a novel human coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), highlights the urgent need to identify a potential drug to combat COVID-19 infection. In this letter, we investigated drug repurposing as an appealing technique that can help with drug development by repurposing existing drugs to treat illnesses apart from their initial indications. The molecular dynamics (MD) simulations using GROMACS (200 ns) were carried out for Vilanterol versus Budesonide towards COVID-19 Mpro. The results indicated that the RMSD, RMSF, Radius of gyration, and Hydrogen-bond analysis favored Vilanterol over Budesonide. Animal investigations and reliable clinical trials will eventually be required to establish the potential preventive and therapeutic effects of these drugs.

Graphical Abstract

[1]
Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: The reality and challenges. J Microbiol Immunol Infect 2020; 53(3): 436-43.
[http://dx.doi.org/10.1016/j.jmii.2020.03.034] [PMID: 32307245]
[2]
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021; 19(3): 141-54.
[http://dx.doi.org/10.1038/s41579-020-00459-7] [PMID: 33024307]
[3]
Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J 2020; 43(4): 328-33.
[http://dx.doi.org/10.1016/j.bj.2020.04.007] [PMID: 32387617]
[4]
Hussain A, Hussain A. Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro. New Microbes New Infect 2022; 47: 100979.
[http://dx.doi.org/10.1016/j.nmni.2022.100979] [PMID: 35433012]
[5]
Mosquera-Yuqui F, Lopez-Guerra N, Moncayo-Palacio EA. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: Molecular docking and molecular dynamics simulations. J Biomol Struct Dyn 2022; 40(5): 2010-23.
[http://dx.doi.org/10.1080/07391102.2020.1835716] [PMID: 33084512]
[6]
Ghahremanian S, Rashidi MM, Raeisi K, Toghraie D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J Mol Liq 2022; 354: 118901.
[http://dx.doi.org/10.1016/j.molliq.2022.118901] [PMID: 35309259]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy